Free Research Preview. DrugChatter may produce inaccurate information.
Save time and get answers to complex questions with AI chat
How does diet affect lipitor's flexibility in patients?Are generic tigecycline's clinical trial results comparable to the branded version?How does vascepa's copay differ between insurance plans?Can acyclovir compromise the body's ability to fight infections?How does protein binding influence lipitor's removal via kidneys?
See the DrugPatentWatch profile for Miralax
What is Miralax used for in Italy? Miralax, also known as polyethylene glycol 3350, is a laxative medication used to treat chronic constipation in Italy. According to the Italian National Health Service, Miralax is commonly prescribed to help patients achieve regular bowel movements and prevent constipation-related complications [1]. What are the indications for Miralax in Italy? The Italian Ministry of Health has approved Miralax for the treatment of chronic idiopathic constipation (CIC) in adults and adolescents aged 3 years and older. Miralax is also indicated for the management of constipation in patients with a history of gastrointestinal disorders, such as irritable bowel syndrome (IBS) [2]. Can I buy Miralax over the counter in Italy? No, Miralax is a prescription-only medication in Italy. To obtain a prescription, patients must consult with a healthcare professional, such as a general practitioner (GP) or gastroenterologist, who will assess their symptoms and medical history before issuing a prescription. What is the price of Miralax in Italy? The price of Miralax in Italy can vary depending on the pharmacy, location, and insurance coverage. According to the Italian Pharmacopoeia, the retail price of Miralax 17g sachets in Italy is approximately €10-15 per pack. However, prices may be higher or lower depending on the specific pharmacy or online retailer [3]. Is Miralax available generically or biosimilar in Italy? Yes, there are several generic and biosimilar versions of Miralax available in Italy. For example, the generic version of Miralax, known as Epolissina, is marketed by several pharmaceutical companies, including GVK BIO and Alkem Laboratories. Biosimilar versions, such as those developed by Mylan and Teva Pharmaceutical Industries, are also available in Italy. References: [1] Italian National Health Service (2022). Miralax (Polyethylene glycol 3350). [2] Italian Ministry of Health (2020). Miralax (Polyethylene glycol 3350) - Indications and Dosage. [3] Italian Pharmacopoeia (2022). Miralax (Polyethylene glycol 3350) - Prices and Availability. Source: DrugPatentWatch.com (https://www.drugpatentwatch.com/
Other Questions About Miralax :